Gene Therapy Using Therapeutic and Diagnostic Recombinant Oncolytic Vaccinia Virus GLV-1h153 for Management of Colorectal Peritoneal Carcinomatosis

Overview

Journal Surgery

Specialty General Surgery

Date 2015 Jan 25

PMID 25616946

Citations 8

Authors

Clarisse Eveno

Kelly Mojica

Justin W Ady

Daniel L J Thorek

Valerie Longo

Laurence J Belin

Sepideh Gholami

Clark Johnsen

Pat Zanzonico

Nanhai Chen

Tony Yu

Aladar A Szalay

Yuman Fong

Affiliations

Soon will be listed here.

Abstract

Background: Peritoneal carcinomatosis (PC) is a terminal progression of colorectal cancer (CRC). Poor response to cytoreductive operation and chemotherapy coupled with the inability to reliably track disease progression by the use of established diagnostic methods, make this a deadly disease. We examined the effectiveness of the oncolytic vaccinia virus GLV-1h153 as a therapeutic and diagnostic vehicle. We believe that viral expression of the human sodium iodide transporter (hNIS) provides both real-time monitoring of viral therapy and effective treatment of colorectal peritoneal carcinomatosis (CRPC).

Methods: Infectivity and cytotoxic effect of GLV-1h153 on CRC cell lines was assayed in vitro. Viral replication was examined by standard viral plaque assays. Orthotopic CRPC xenografts were generated in athymic nude mice and subsequently administered GLV-1h153 intraperitoneally. A decrease in tumor burden was assessed by mass. Orthotopic tumors were visualized by single-photon emission computed tomography/computed tomography after Iodine ((131)I) administration and by fluorescence optical imaging.

Results: GLV-1h153 infected and killed CRC cells in a time- and concentration-dependent manner. Viral replication demonstrated greater than a 2.35 log increase in titer over 4 days. Intraperitoneal treatment of orthotopic CRPC xenografts resulted in a substantial decrease in tumor burden. Infection of orthotopic xenografts was therapeutic and facilitated monitoring by (131)I-single-photon emission computed tomography/computed tomography via expression of hNIS in infected tissue.

Conclusion: GLV-1h153 kills CRC in vitro effectively and decreases tumor burden in vivo. We demonstrate that GLV-1h153 can be used as an agent to provide accurate delineation of tumor burden in vivo. These findings indicate that GLV-1h153 has potential for use as a therapeutic and diagnostic agent in the treatment of CRPC.

Citing Articles

Emerging therapeutic approaches for peritoneal metastases from gastrointestinal cancers.

Sikora A, Sullivan K, Dineen S, Raoof M, Karolak A Mol Ther Oncol. 2024; 32(1):200767.

PMID: 38596287 PMC: 10873742. DOI: 10.1016/j.omton.2024.200767.

Efficacy of Different Oncolytic Vaccinia Virus Strains for the Treatment of Murine Peritoneal Mesothelioma.

Yurttas C, Beil J, Berchtold S, Smirnow I, Kloker L, Sipos B Cancers (Basel). 2024; 16(2).

PMID: 38254857 PMC: 10814383. DOI: 10.3390/cancers16020368.

The employment of vaccinia virus for colorectal cancer treatment: A review of preclinical and clinical studies.

Ling Q, Zheng B, Chen X, Ye S, Cheng Q Hum Vaccin Immunother. 2022; 18(6):2143698.

PMID: 36369829 PMC: 9746450. DOI: 10.1080/21645515.2022.2143698.

Immuno-Oncolytic Viruses: Emerging Options in the Treatment of Colorectal Cancer.

Kana S, Essani K Mol Diagn Ther. 2021; 25(3):301-313.

PMID: 33713031 DOI: 10.1007/s40291-021-00517-7.

IL-24-Armed Oncolytic Vaccinia Virus Exerts Potent Antitumor Effects via Multiple Pathways in Colorectal Cancer.

Deng L, Yang X, Fan J, Ding Y, Peng Y, Xu D Oncol Res. 2020; 28(6):579-590.

PMID: 32641200 PMC: 7962938. DOI: 10.3727/096504020X15942028641011.

References

Cao C, Yan T, Black D, Morris D . A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2009; 16(8):2152-65. DOI: 10.1245/s10434-009-0487-4. View

Hingorani M, Spitzweg C, Vassaux G, Newbold K, Melcher A, Pandha H . The biology of the sodium iodide symporter and its potential for targeted gene delivery. Curr Cancer Drug Targets. 2010; 10(2):242-67. PMC: 3916908. DOI: 10.2174/156800910791054194. View

Esquivel J, Chua T, Stojadinovic A, Torres Melero J, Levine E, Gutman M . Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol. 2010; 102(6):565-70. DOI: 10.1002/jso.21601. View

Haddad D, Chen N, Zhang Q, Chen C, Yu Y, Gonzalez L . Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus. J Transl Med. 2011; 9:36. PMC: 3080806. DOI: 10.1186/1479-5876-9-36. View

van Dam G, Themelis G, Crane L, Harlaar N, Pleijhuis R, Kelder W . Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nat Med. 2011; 17(10):1315-9. DOI: 10.1038/nm.2472. View

Gholami S, Haddad D, Chen C, Chen N, Zhang Q, Zanzonico P . Novel therapy for anaplastic thyroid carcinoma cells using an oncolytic vaccinia virus carrying the human sodium iodide symporter. Surgery. 2011; 150(6):1040-7. DOI: 10.1016/j.surg.2011.09.010. View

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1):10-29. DOI: 10.3322/caac.20138. View

Gholami S, Chen C, Lou E, Brot M, Fujisawa S, Chen N . Vaccinia virus GLV-1h153 is effective in treating and preventing metastatic triple-negative breast cancer. Ann Surg. 2012; 256(3):437-45. DOI: 10.1097/SLA.0b013e3182654572. View

Belin L, Ady J, Lewis C, Marano D, Gholami S, Mojica K . An oncolytic vaccinia virus expressing the human sodium iodine symporter prolongs survival and facilitates SPECT/CT imaging in an orthotopic model of malignant pleural mesothelioma. Surgery. 2013; 154(3):486-95. PMC: 4123996. DOI: 10.1016/j.surg.2013.06.004. View

10.

Thorek D, Ogirala A, Beattie B, Grimm J . Quantitative imaging of disease signatures through radioactive decay signal conversion. Nat Med. 2013; 19(10):1345-50. PMC: 3795968. DOI: 10.1038/nm.3323. View

11.

Ottolino-Perry K, Tang N, Head R, Ng C, Arulanandam R, Angarita F . Tumor vascularization is critical for oncolytic vaccinia virus treatment of peritoneal carcinomatosis. Int J Cancer. 2013; 134(3):717-30. DOI: 10.1002/ijc.28395. View

12.

Gholami S, Chen C, Belin L, Lou E, Fujisawa S, Antonacci C . Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer. Breast Cancer Res. 2013; 15(2):R26. PMC: 3672815. DOI: 10.1186/bcr3404. View

13.

Sadeghi B, Arvieux C, Glehen O, Beaujard A, Rivoire M, Baulieux J . Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000; 88(2):358-63. DOI: 10.1002/(sici)1097-0142(20000115)88:2<358::aid-cncr16>3.0.co;2-o. View

14.

Jayne D, Fook S, Loi C, Seow-Choen F . Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002; 89(12):1545-50. DOI: 10.1046/j.1365-2168.2002.02274.x. View

15.

Pilati P, Mocellin S, Rossi C, Foletto M, Campana L, Nitti D . Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol. 2003; 10(5):508-13. DOI: 10.1245/aso.2003.08.004. View

16.

Verwaal V, van Ruth S, de Bree E, van Sloothen G, van Tinteren H, Boot H . Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003; 21(20):3737-43. DOI: 10.1200/JCO.2003.04.187. View

17.

Mahteme H, Hansson J, Berglund A, Pahlman L, Glimelius B, Nygren P . Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study. Br J Cancer. 2004; 90(2):403-7. PMC: 2409568. DOI: 10.1038/sj.bjc.6601586. View

18.

Glehen O, Mohamed F, Gilly F . Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol. 2004; 5(4):219-28. DOI: 10.1016/S1470-2045(04)01425-1. View

19.

de Bree E, Koops W, Kroger R, van Ruth S, Witkamp A, Zoetmulder F . Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol. 2004; 86(2):64-73. DOI: 10.1002/jso.20049. View

20.

Glehen O, Kwiatkowski F, Sugarbaker P, Elias D, Levine E, de Simone M . Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004; 22(16):3284-92. DOI: 10.1200/JCO.2004.10.012. View